Joint US/Korean effort for bio C4

摘要

US-based bioscience company Metabolix has entered into a joint development agreement with South Korea-based CJ Bio, a division of industrial biotechnology company CJ CheilJedang, to advance production technology and assess investment options for renewable C4 chemicals via fermentation. The C4 chemical market is a US$3 billion industry growing at 4% a year with chemical products used in a wide range of applications, including engineering resins. fabrics and fibres, personal care products and in semiconductor manufacturing.